Ashlee Dunston | Director, Investor Relations & Corporate Communications |
Sanjay Shukla | President & Chief Executive Officer |
Jill Broadfoot | Chief Financial Officer |
Gregory Renza | RBC Capital Markets |
Sara Nik | H.C. Wainwright |
Yale Jen | Laidlaw |
Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session and instructions will be given at that time.
As a reminder, this conference call is being recorded for replay purposes.
It is now my pleasure to hand the conference over to Ashlee Dunston, aTyr’s Director of Investor Relations and Corporate Communications.